GROUP ONE TRADING, L.P. - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 36 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$2,0000.0%5,922
-16.9%
0.00%
Q3 2019$2,000
-60.0%
7,124
-64.6%
0.00%
Q2 2019$5,000
-92.3%
20,151
-66.7%
0.00%
-100.0%
Q1 2019$65,000
-82.7%
60,575
-72.2%
0.00%
-66.7%
Q4 2018$376,000
-73.0%
217,600
-9.3%
0.00%
-72.7%
Q3 2018$1,392,000
+677.7%
239,928
+473.4%
0.01%
+450.0%
Q2 2018$179,000
+64.2%
41,841
+124.6%
0.00%
+100.0%
Q1 2018$109,000
+7.9%
18,631
-14.6%
0.00%0.0%
Q4 2017$101,000
-29.4%
21,804
-16.4%
0.00%0.0%
Q3 2017$143,000
-44.6%
26,076
-41.7%
0.00%
-66.7%
Q2 2017$258,000
+10.7%
44,708
+10.8%
0.00%0.0%
Q1 2017$233,000
+1270.6%
40,333
+1164.8%
0.00%
Q4 2016$17,000
-51.4%
3,189
-81.9%
0.00%
Q3 2016$35,000
-39.7%
17,628
-37.3%
0.00%
-100.0%
Q2 2016$58,000
+41.5%
28,134
+45.1%
0.00%0.0%
Q1 2016$41,000
+2.5%
19,385
+41.3%
0.00%
Q4 2015$40,000
+60.0%
13,720
+147.6%
0.00%
Q3 2015$25,000
-89.9%
5,542
-88.4%
0.00%
-100.0%
Q2 2015$247,000
+97.6%
47,916
+173.7%
0.00%
+50.0%
Q1 2015$125,000
-13.2%
17,505
-14.8%
0.00%0.0%
Q4 2014$144,000
-5.3%
20,546
-17.5%
0.00%0.0%
Q3 2014$152,000
+78.8%
24,901
+167.4%
0.00%
+100.0%
Q2 2014$85,0009,3130.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,192,080$6,545,0003.19%
COURAGE CAPITAL MANAGEMENT LLC 200,000$1,098,0000.74%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 174,512$958,0000.06%
Family Management Corp 14,000$77,0000.05%
EAM Investors, LLC 62,752$345,0000.05%
FNY Managed Accounts LLC 4,400$24,0000.03%
ACADIAN ASSET MANAGEMENT LLC 1,090,397$5,988,0000.03%
REILLY FINANCIAL ADVISORS, LLC 22,011$121,0000.02%
Alambic Investment Management, L.P. 28,500$156,0000.02%
Caprock Group, LLC 14,085$77,0000.02%
View complete list of CONATUS PHARMACEUTICALS INC shareholders